References
- Wang WL, Xu SY, Ren ZG, et al. Application of metagenomics in the human gut microbiome. World J Gastroenterol. 2015;21(3):803–814.
- Gjesing AP, Pedersen O. ‘Omics’-driven discoveries in prevention and treatment of type 2 diabetes. Eur J Clin Invest. 2012;42(6):579–588.
- Langille MGI, Zaneveld J, Caporaso JG, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31(9):814–821.
- Wang Y, Ames NP, Tun HM, et al. High molecular weight barley β-glucan alters gut microbiota toward reduced cardiovascular disease risk. Front Microbiol. 2016;7:129.
- Land M, Hauser L, Jun SR, et al. Insights from 20 years of bacterial genome sequencing. Funct Integr Genomics. 2015;15(2):141–161.
- Mondot S, Lepage P. The human gut microbiome and its dysfunctions through the meta-omics prism. Ann N Y Acad Sci. 2016. doi:10.1111/nyas.13033
- Wissenbach DK, Oliphant K, Rolle-Kampczyk U, et al. Optimization of metabolomics of defined in vitro gut microbial ecosystems. Int J Med Microbiol. 2016. doi:10.1016/j.ijmm.2016.03.007
- Smirnov KS, Maier TV, Walker A, et al. Challenges of metabolomics in human gut microbiota research. Int J Med Microbiol. 2016. doi:10.1016/j.ijmm.2016.03.006
- Verberkmoes NC, Russell AL, Shah M, et al. Shotgun metaproteomics of the human distal gut microbiota. ISME J. 2009;3(2):179–189.
- Xiong W, Abraham PE, Li Z, et al. Microbial metaproteomics for characterizing the range of metabolic functions and activities of human gut microbiota. Proteomics. 2015;15(20):3424–3438.
- Woting A, Pfeiffer N, Loh G, et al. Clostridium ramosum promotes high-fat diet-induced obesity in gnotobiotic mouse models. mBio. 2014;5(5):e01530–e01514.
- Slezak K, Krupova Z, Rabot S, et al. Association of germ-free mice with a simplified human intestinal microbiota results in a shortened intestine. Gut Microbes. 2014;5(2):176–182.
- Haange SB, Oberbach A, Schlichting N, et al. Metaproteome analysis and molecular genetics of rat intestinal microbiota reveals section and localization resolved species distribution and enzymatic functionalities. J Proteome Res. 2012;11(11):5406–5417.
- Ferrer M, Ruiz A, Lanza F, et al. Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure. Environ Microbiol. 2013;15(1):211–226.
- Schaubeck M, Clavel T, Calasan J, et al. Dysbiotic gut microbiota causes transmissible Crohn’s disease-like ileitis independent of failure in antimicrobial defence. Gut. 2016;65(2):225–237.
- Chen R, Mias GI, Li-Pook-Than J, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell. 2012;148(6):1293–1307.
- Schmidt A, Kochanowski K, Vedelaar S, et al. The quantitative and condition-dependent Escherichia coli proteome. Nat Biotechnol. 2016;34(1):104–110.
- Wöhlbrand L, Trautwein K, Rabus R. Proteomic tools for environmental microbiology – a roadmap from sample preparation to protein identification and quantification. Proteomics. 2013;13(18–19):2700–2730.
- Lichtman JS, Marcobal A, Sonnenburg JL, et al. Host-centric proteomics of stool: a novel strategy focused on intestinal responses to the gut microbiota. Mol Cell Proteomics. 2013;12(11):3310–3318.
- Morgan XC, Huttenhower C. Meta’omic analytic techniques for studying the intestinal microbiome. Gastroenterology. 2014;146(6):1437–1448 e1431.